The Impact of Malnutrition on Immune Responses to Tuberculosis
TBMAM
1 other identifier
observational
200
1 country
2
Brief Summary
The aim of this study is to assess immune responses to Mtb in children with MAM compared to well-nourished children and to evaluate the impact of a nutrition intervention on these immune responses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2020
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2020
CompletedFirst Submitted
Initial submission to the registry
September 9, 2021
CompletedFirst Posted
Study publicly available on registry
September 16, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedMay 29, 2024
May 1, 2024
4.1 years
September 9, 2021
May 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
IFNγ concentration
IFNγ concentration in supernatant after overnight incubation of whole blood with TB antigens
6 months
Study Arms (4)
MAM children with TB disease
Wellnourished children with TB disease
MAM children with latent TB infection
Well-nourished children with latent TB infection
Interventions
Children with malnutrition will be given RUSF
Eligibility Criteria
HIV negative, BCG vaccinated
You may qualify if:
- Age 12-60 months
- HIV-negative
- BCG vaccinated
- Moderate acute malnutrition (WHZ -2 to -3 or MUAC 115 - 125mm ± HAZ \<-2)
- TB disease
- Latent TB infection
You may not qualify if:
- Severe acute malnutrition (WHZ\<-3; MUAC\<115mm; bilateral oedema)
- Severe anaemia (Hb: \<7g/dl)
- Chronic infection (HIV, hepatitis B or C)
- Chronic disease (e.g. Crohn's disease)
- Feeding problems (eg cerebral palsy) that prevent ingestion of RUSF
- Known nut allergy
- MDR TB disease and contacts of MDR TB adults
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tuberculosis Research Centre, Indialead
- Institute of Child Health, Madras Medical College, Chennaicollaborator
- Stanley Medical Collegecollaborator
- Kanchi Kamakoti Childs Trust Hospital, Chennai, Indiacollaborator
- Queen Mary University of Londoncollaborator
- London School of Hygiene and Tropical Medicinecollaborator
- DBT, Indiacollaborator
Study Sites (2)
Institute of Child Health
Chennai, Tamil Nadu, 600 008, India
Government Stanley Medical College and Hospital
Chennai, Tamil Nadu, 600001, India
Related Publications (1)
Venkataraman A, Shanmugam S, Balaji S, Mani K, Shanmugavel AK, Muthuramalingam K, Hissar S, Thiruvengadam K, Selladurai E, Smuk M, Hanna LE, Prendergast AJ. Comparison of two mycobacterial strains in performance of the whole blood mycobacterial growth inhibition assay in Indian children. Tuberculosis (Edinb). 2022 Dec;137:102255. doi: 10.1016/j.tube.2022.102255. Epub 2022 Aug 31.
PMID: 36252397DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aishwarya Venkataraman, MRCPCH
ICMR-NIRT
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 9, 2021
First Posted
September 16, 2021
Study Start
August 1, 2020
Primary Completion
August 31, 2024
Study Completion
December 1, 2024
Last Updated
May 29, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share
Data will be shared according to ICMR rules and regulations after appropriate approvals